Galapagos reported -32355000 in Operating Profit for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
AstraZeneca AZN:LN 1.17B 113M
Biogen BIIB:US $ 1086.4M 888.1M
Genmab GEN:DC 858M 3.64B
Gilead Sciences GILD:US $ -2983M 5385M
GlaxoSmithKline GSK:LN 285M 83.6M
Merck MRK:GR € 491M 225M
Neurocrine Biosciences NBIX:US $ 76M 18M
Novartis NOVN:VX 2.35B 392M
Vertex Pharmaceuticals VRTX:US $ 718.03M 2.19M
YTE INCY:US $ 230.77M 894.78M